Aeluma Files Two New Patent Applications Related to Quantum Computing and Sensing

Aeluma, Inc. (OTCQB:ALMU), a semiconductor company specializing in high performance, scalable technologies

Intuitive Venture PartnersDecember 16, 2024aeluma, 2024

Aeluma to Showcase Breakthrough Technologies at SPIE Photonics West January 28 - 30, 2025 in San Francisco, California

Aeluma, Inc. (OTCQB:ALMU), a semiconductor company specializing in high performance, scalable technologies for

Intuitive Venture PartnersDecember 12, 2024aeluma, 2024

Aeluma Secures NASA Contract to Advance Quantum Dot Photonic Integrated Circuits for Aerospace and AI Applications

Aeluma, Inc., (OTCQB:ALMU), a semiconductor company specializing in high-performance, scalable technologies

Intuitive Venture PartnersNovember 21, 2024Aeluma, 2024

Lumicell Awarded Phase I NIH SBIR Contract to Develop Novel Flexible Endoscope for Fluorescence Imaging of LUMISIGHT™ to Detect Early Esophageal Lesions in Patients with Barrett’s Esophagus

Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided

Intuitive Venture PartnersOctober 9, 20242024, Lumicell

Serve Robotics and Wing Partner to Expand Autonomous Delivery, Increasing Reach and Efficiency

Serve Robotics Inc. ("Serve") (Nasdaq: SERV), a leading autonomous sidewalk

Intuitive Venture PartnersOctober 5, 20242024, Serve Robotics

Aeluma Wins $11.717 Million DARPA Contract for Nano-Scale Semiconductors

Aeluma, Inc. (OTCQB:ALMU), a semiconductor company specializing in high performance,

Intuitive Venture PartnersSeptember 21, 2024aeluma, 2024

Aeluma Achieves ISO 9001:2015 Certification for Quality Management System

Aeluma, Inc. (OTCQB:ALMU), a semiconductor company specializing in high performance, scalable technologies for

Intuitive Venture PartnersSeptember 16, 2024aeluma, 2024

CMS Grants Transitional Pass-Through Payment for LUMISIGHT™ (pegulicianine) and Increases Access for Patients with Breast Cancer

Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided

Intuitive Venture PartnersSeptember 7, 20242024, Lumicell

Serve Robotics and Shake Shack Roll Out Autonomous Robot Delivery Via Uber Eats

Serve Robotics, Inc.; ("Serve") (Nasdaq: SERV), a leading autonomous sidewalk

Intuitive Venture PartnersAugust 14, 2024Serve Robotics, 2024

Serve Robotics Announces Pricing of $15.0 Million Private Placement

Serve Robotics, Inc.. ("Serve") (Nasdaq: SERV), a leading autonomous delivery robotics company, today announced

Intuitive Venture PartnersJuly 24, 20242024, Serve Robotics

Aeluma Wins Another Funding Award from the Office of Secretary of Defense

Aeluma, Inc. (OTCQB:ALMU), a semiconductor company specializing in high performance

Intuitive Venture PartnersMay 31, 20242024, Aeluma

Serve Robotics Announces First Quarter 2024 Results and Provides Corporate Update

Serve Robotics Announces First Quarter 2024

Intuitive Venture PartnersMay 15, 20242024, Serve Robotics

Guerrilla RF Completes Strategic Acquisition of GaN Device Portfolio from Gallium Semiconductor

Guerrilla RF, Inc. (OTCQX: GUER) has finalized the

Intuitive Venture PartnersApril 29, 2024Guerilla, 2024

Lumicell’s Cutting-Edge Imaging Platform Receives Historic FDA Approval to Illuminate Residual Breast Cancer

Lumicell, Inc., a privately held company focused on developing innovative

Intuitive Venture PartnersApril 18, 20242024, Lumicell

Serve Robotics Inc. Announces Pricing of $40 Million Public Offering and Uplisting to the Nasdaq Capital Market Under New Ticker "SERV"

Serve Robotics Inc. (the "Company" or "Serve"), a leading autonomous sidewalk

Intuitive Venture PartnersApril 17, 20242024, Serve Robotics

Entera Bio Announces Publication of Oral PTH(1-34) Peptide Tablets (EB613) Phase 2 Trial Data in the Journal of Bone and Mineral Research

Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in

Intuitive Venture PartnersApril 8, 20242024, entera bio

Entera Bio Announces Key Regulatory Milestone for Oral PTH(1-34) Peptide (EB613) Phase 3 Program: FDA Ruling on Qualifying BMD as a Surrogate Endpoint

Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader

Intuitive Venture PartnersMarch 26, 20242024, entera bio

Lumicell Introduces Further Research and Insights in Fluorescence-Guided Surgery at the Society of Surgical Oncology (SSO) Annual Meeting

Lumicell Inc., a privately held company focused on

Intuitive Venture PartnersMarch 26, 20242024, Lumicell

Lumicell Announces FDA Advisory Committee’s Positive Recommendation on the Benefit-Risk Profile of LUMISIGHT™ in the Detection of Cancerous Tissue During Breast Conserving Surgery

Lumicell, Inc., a privately held company focused on innovative

Intuitive Venture PartnersMarch 6, 2024Lumicell, 2024

Lumicell Announces Initial Data Demonstrating LUMISIGHT™’s Ability to Detect Tumors Metastasized to Multiple Organs in the Peritoneum

Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies for cancer surgery, today announced

Intuitive Venture PartnersMarch 4, 20242024, Lumicell